Primonoc Tablet 80 mg (Telmisartan)

Adult dose

Telmisartan should be administered orally 40 mg once daily with water, irrespective of meals. If necessary, treatment may start with 20 mg once daily, and can be increased up to a maximum of 80 mg once daily. For reducing cardiovascular disease risk, it is recommended to take 80 mg once daily. For patients with liver impairment, the dosage should not exceed 40 mg once daily.

This medication may cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to patients with hypersensitivity to this drug, pregnant or breastfeeding women, severe liver impairment patients, hereditary angioedema patients, and certain renal impairment patients. Caution should be exercised for elderly patients, hyperkalemia patients, mild to moderate liver impairment patients, patients with valvular heart disease, and patients with ischemic heart disease. Various adverse reactions may occur during treatment with this medication; hence, special attention should be paid to symptoms such as hypotension, renal function abnormalities, hyperkalemia, and angioedema. For patients with renal impairment or those with reduced blood volume, their condition should be corrected before administration, and appropriate measures should be taken if symptoms of hypotension arise. This drug can interact with other antihypertensives, particularly when used with RAAS agents, increasing the risk of renal function deterioration and hyperkalemia. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should avoid taking it or discontinue breastfeeding. It is not recommended for children as safety and efficacy have not been established. In the elderly, close monitoring is required to reduce the risk of stroke due to excessive blood pressure lowering. In case of overdose, symptoms such as hypotension, dizziness, acute renal failure may appear, requiring immediate treatment, and this drug is not removed by dialysis. This medication should be kept out of reach of children, and packaging should be opened just before use. Caution is advised when driving or operating machinery, as fainting or dizziness may occur. If abnormal symptoms occur during the course of treatment, prompt consultation with healthcare professionals is required.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty in breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin shedding, pain in oral/eye mucosa, severe skin reactions, difficulty in breathing or shortness of breath, asthmatic attacks, respiratory difficulties associated with cough and fever, jaundice (yellowing of skin or eyes), severe lethargy, liver dysfunction (jaundice), sudden and

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at a temperature between 1°C and 30°C. Proper storage helps maintain the drug's efficacy and prevents deterioration.

Appearance

White or nearly white, biconvex, round tablets

Package unit

10 tablets/blister X 3